The role of immune inflammation in aneurysmal subarachnoid hemorrhage.

作者: Zeyu Zhang , Yuanjian Fang , Cameron Lenahan , Sheng Chen

DOI: 10.1016/J.EXPNEUROL.2020.113535

关键词:

摘要: Abstract Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating disease, which mainly caused by the rupture of an intracranial aneurysm. Clinical trials have demonstrated that cerebral vasospasm (CVS) not sole contributor to delayed ischemia (DCI) and poor outcomes in patients with aSAH. Currently, accumulating evidence suggests early brain injury (EBI), occurs within 72 h after onset aSAH, lays foundation for subsequent pathophysiological changes patients. The pathological mechanisms EBI include increased pressure, oxidative stress, neuroinflammation, blood-brain barrier (BBB) disruption, edema cell death. Among them, immune inflammatory responses involve variety cells active substances, play important role aSAH may be related DCI long-term outcomes. Thus, attention should paid strategies targeting responses. In this review, we discuss occurrence development as well some biomarkers CVS, DCI, addition, also summarize potential therapeutic drugs target current research.

参考文章(135)
Sherry H.-Y. Chou, Steven K. Feske, Juli Atherton, Rachael G. Konigsberg, Philip L. De Jager, Rose Du, Christopher S. Ogilvy, Eng H. Lo, MingMing Ning, Early elevation of serum tumor necrosis factor-α is associated with poor outcome in subarachnoid hemorrhage. Journal of Investigative Medicine. ,vol. 60, pp. 1054- 1058 ,(2012) , 10.2310/JIM.0B013E3182686932
Ulf C. Schneider, Anja-Maria Davids, Susan Brandenburg, Annett Müller, Anna Elke, Salima Magrini, Etienne Atangana, Kati Turkowski, Tobias Finger, Angelika Gutenberg, Claire Gehlhaar, Wolfgang Brück, Frank L. Heppner, Peter Vajkoczy, Microglia inflict delayed brain injury after subarachnoid hemorrhage. Acta Neuropathologica. ,vol. 130, pp. 215- 231 ,(2015) , 10.1007/S00401-015-1440-1
Chi Gu, Yifei Wang, Jianru Li, Jingyin Chen, Feng Yan, Cheng Wu, Gao Chen, None, Rosiglitazone attenuates early brain injury after experimental subarachnoid hemorrhage in rats Brain Research. ,vol. 1624, pp. 199- 207 ,(2015) , 10.1016/J.BRAINRES.2015.07.025
Ruben Orihuela, Christopher A McPherson, Gaylia Jean Harry, Microglial M1/M2 polarization and metabolic states British Journal of Pharmacology. ,vol. 173, pp. 649- 665 ,(2016) , 10.1111/BPH.13139
Joshua D. Bell, Theresa Currier Thomas, Elliot Lass, Jinglu Ai, Hoyee Wan, Jonathan Lifshitz, Andrew J. Baker, R. Loch Macdonald, Platelet-mediated changes to neuronal glutamate receptor expression at sites of microthrombosis following experimental subarachnoid hemorrhage Journal of Neurosurgery. ,vol. 121, pp. 1424- 1431 ,(2014) , 10.3171/2014.3.JNS132130
Seyed Mohammad Ghodsi, Ahmad Aoude, Niayesh Mohebbi, Soheil Naderi, Mousareza Anbarloie, Seyed Sohail Habibi Pasdar, Comparative Efficacy of Meloxicam and Placebo in Vasospasm of Patients with Subarachnoid Hemorrhage Iranian Journal of Pharmaceutical Research. ,vol. 14, pp. 125- 130 ,(2015) , 10.22037/IJPR.2015.1633
Mutsumi Fujii, Junhao Yan, William B. Rolland, Yoshiteru Soejima, Basak Caner, John H. Zhang, Early Brain Injury, an Evolving Frontier in Subarachnoid Hemorrhage Research Translational Stroke Research. ,vol. 4, pp. 432- 446 ,(2013) , 10.1007/S12975-013-0257-2
Bo-Feng Lin, Chan-Yang Kuo, Li-Li Wen, Chun-Mei Chen, Ya-Feng Chang, Chih-Shung Wong, Chen-Hwan Cherng, Mei-Yu Chuang, Zhi-Fu Wu, Rosiglitazone Attenuates Cerebral Vasospasm and Provides Neuroprotection in an Experimental Rat Model of Subarachnoid Hemorrhage Neurocritical Care. ,vol. 21, pp. 316- 331 ,(2014) , 10.1007/S12028-014-0010-Z
Yuxiang Dai, Qing Sun, Xing Zhang, Yangchun Hu, Mengliang Zhou, Jixin Shi, Cyclosporin A ameliorates early brain injury after subarachnoid hemorrhage through inhibition of a Nur77 dependent apoptosis pathway Brain Research. ,vol. 1556, pp. 67- 76 ,(2014) , 10.1016/J.BRAINRES.2014.01.052
John D. Belcher, Chunsheng Chen, Julia Nguyen, Liming Milbauer, Fuad Abdulla, Abdu I. Alayash, Ann Smith, Karl A. Nath, Robert P. Hebbel, Gregory M. Vercellotti, Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease Blood. ,vol. 123, pp. 377- 390 ,(2014) , 10.1182/BLOOD-2013-04-495887